.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for introduction of people with MASLD and size of liver end results in cardio-- renal-- metabolic trials, when data recommend mechanistically tenable advantages as well as medical protection-- and also details factors to consider for trial concept and regulative commendation.